title: Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment.
authors.affiliation: Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA; Department of Global Health Sciences, University of California, San Francisco, San Francisco, California, USA;
authors.forename: George W
authors.initials: GW
authors.lastname: Rutherford
authors.affiliation: Department of Health, Human Services and Public Policy, California State University Monterey Bay, Seaside, California, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Anglemyer
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D005260:Female; D006679:HIV Seropositivity / Q000188:drug therapy*; D006801:Humans; D008297:Male
chemical_list: D044966:Anti-Retroviral Agents